Skip to main content

Market Overview

Why Aptevo Therapeutics Is Trading Higher Today


Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher on Tuesday, after the company announced it regained compliance with the NASDAQ listing requirements.

Aptevo Therapeutics is a clinical-stage biotechnology company, engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics in the U.S.

Aptevo Therapeutics shares were trading 8.24% higher at $4.07 on Tuesday. The stock has a 52-week high of $14.56 and a 52-week low of 27 cents.


Related Articles (APVO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Legal

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at